Business Standard

Pharma shares under pressure;Glenmark hits 52-week low, Sun Pharma falls 6%

Marksans Pharma, Ajanta Pharma, Morepen Lab, Alkem Laboratories, SPARC and Aarti Drugs were down in the range 3% to 4% on the BSE.

Pharmaceuticals, drugs, pharma industry, medical, health, lab
Premium

SI Reporter Mumbai
Shares of select pharmaceutical companies were under pressure, falling by up to 6% ahead of US President Donald Trump speech today about controlling prescription drug prices.

Sun Pharmaceutical Industries slipped 6% to Rs 468 on the BSE in noon deal on back of heavy volumes. Novartis India, Marksans Pharma, Ajanta Pharma, Morepen Laboratories, Alkem Laboratories, Sun Pharma Advanced Research Company (SPARC) and Aarti Drugs were down in the range 3% to 4% on the BSE.

At 02:17 pm; S&P BSE Healthcare index was down 1%, while Nifty Pharma index dipped 1.5%, as compared to 0.5% rise in the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in